|
| |
| Return on Investment for Bariatric Surgery |
|
| Eric A. Finkelstein, PhD, MHA; and Derek S. Brown, PhD |
|
| In this issue of the Journal, Crémieux and colleagues1 report on an analysis of the return on investment for bariatric surgery. |
|
| |
| Metastatic Non–Small Cell Lung Cancer: Costs Associated With Disease Progression |
|
| Kathleen M. Fox, MHS, PhD; John M. Brooks, PhD; and Jennifer Kim, PharmD |
|
| Lung cancer is the leading cause of cancer death in the United States and worldwide1,2 and was the third most frequently diagnosed cancer in the United States in 2002. |
|
| |
| Validating the Framingham Offspring Study Equations for Predicting Incident Diabetes Mellitus |
|
| Gregory A. Nichols, PhD; and Jonathan B. Brown, PhD, MPP
|
|
| Although the prevalence and incidence of type 2 diabetes mellitus (DM) continue to increase at an alarming rate,1 many at-risk patients do not develop DM.2 Accurate prediction of DM onset may help target interventions to prevent DM and facilitate the efficient allocation of healthcare resources.
|
|
| |
| Medicine Reimbursement Recommendations in Canada, Australia, and Scotland |
|
| Joel Lexchin, MD; and Barbara Mintzes, PhD |
|
| Payment for drugs prescribed outside of hospitals is not included within the basic set of healthcare services covered by Medicare in Canada. |
|
| |
| A Study on the Economic Impact of Bariatric Surgery |
|
| Pierre-Yves Crémieux, PhD; Henry Buchwald, MD, PhD; Scott A. Shikora, MD; Arindam Ghosh, PhD; Haixia Elaine Yang, PhD; and Marric Buessing, BA |
|
| The prevalence of obesity among the US adult population has increased steadily to reach one third of the US adult population. |
|
| |
| Long-term Economic Benefits Attributed to IVF-conceived Children: A Lifetime Tax Calculation |
|
| Mark P. Connolly, MHE; Michael S. Pollard, PhD; Stijn Hoorens, MSc; Brian R. Kaplan, MD; Selwyn P. Oskowitz, MD; and Sherman J. Silber, MD |
|
| The past decade has witnessed a dramatic increase in the demand for assisted reproductive technology (ART ) such as in vitro fertilization (IVF). |
|
| |
| Therapies for Treatment of Osteoporosis in US Women: Cost-effectiveness and Budget Impact Considerations |
|
| Anna N. A. Tosteson, ScD; Russel T. Burge, PhD; Deborah A. Marshall, PhD; and Robert Lindsay, MD |
|
| Osteoporosis has been defined as a skeletal disorder characterized by compromised bone strength predisposing a person to an increased risk of fracture. |
|
| |
| Utilization Outcomes and Patient Cost Sharing |
|
| Kathleen A. Fairman, MA. Author reply by Michael E. Chernew, PhD, and Joseph P. Newhouse, PhD |
|
| The conclusions of Chernew and Newhouse's commentary on the effects of cost sharing (July 2008)1 were based on an inaccurate presentation of currently available research evidence. |
|
| |
| Complementary and Alternative Medicine in Cancer Care |
|
| Christopher N. Mills, MD, MPH. Author reply by William E. Lafferty, MD, and M. Robyn Andersen, PhD, MPH |
|
| In the May 2008 issue, I read with interest the article by Lafferty et al regarding complementary and alternative medicine (CAM) use among cancer patients under mandatory insurance coverage. |
|
| |
| Ezetimibe 5 and 10 mg for Lowering LDL-C: Potential Billion-Dollar Savings With Improved Tolerability |
|
| Lawrence Baruch, MD; Bhanu Gupta, MD; Sharon S. Lieberman-Blum, PharmD; Sanjay Agarwal, MD; and Calvin Eng, MD |
|
| This retrospective study strongly suggests that splitting a 10-mg ezetimibe tablet yields a 5-mg dose that is clinically equivalent to the 10-mg dose. |
|
| |
| Health System Correlates of Receipt of Radiation Therapy After Breast-Conserving Surgery: A Study of Low-Income Medicaid-Enrolled Women |
|
| Roger T. Anderson, PhD; Gretchen G. Kimmick, MD, MS; Fabian Camacho, MS; J. Timothy Whitmire, PhD; Carol Dickinson, CTR; Edward A. Levine, MD; Frank M. Torti, MD, MPH; and Rajesh Balkrishnan, PhD |
|
|
|
| |
| Are Primary Care Physicians Ready to Practice in a Consumer-Driven Environment? |
|
| Giridhar Mallya, MD; Craig Evan Pollack, MD, MHS; and Daniel Polsky, PhD |
|
|
|
| |
| Bridges to Excellence—Recognizing High-Quality Care: Analysis of Physician Quality and Resource Use |
|
| Meredith B. Rosenthal, PhD; Francois S. de Brantes, MBA; Anna D. Sinaiko, MPP; Matthew Frankel, MBA; Russell D. Robbins, MD, MBA; and Sara Young, MBA |
|
| Physicians recognized as high quality by Bridges to Excellence performed better than their peers on claims based quality measures and, in some cases, on resource use measures. |
|
| |
| Medicare Capitation Model, Functional Status, and Multiple Comorbidities: Model Accuracy |
|
| Katia Noyes, PhD, MPH; Hangsheng Liu, PhD; and Helena Temkin-Greener, PhD, MPH |
|
| This study of financial implications of risk adjustment for Medicare payments to individuals with comorbidities and functional impairment demonstrates the importance of controlling for disability. |
|
| |
| Trends in Out-of-Pocket Healthcare Costs Among Older Community-Dwelling Medicare Beneficiaries |
|
| Gerald F. Riley, MSPH |
|
|
|
| |
.jpg "Cardiology Review")
